Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In February 2012, the novel respiratory syncytial virus (RSV) group A, genotype ON1, was detected in Kilifi County, coastal Kenya. ON1 is characterized by a 72-nt duplication within the highly variable G gene (encoding the immunogenic attachment surface protein). Cases were diagnosed through surveillance of pneumonia in children at the county hospital. Analysis of epidemiologic, clinical, and sequence data of RSV-A viruses detected over 5 RSV seasons (2010/2011 to 2014/2015) indicated the following: 1) replacement of previously circulating genotype GA2 ON1, 2) an abrupt expansion in the number of ON1 variants detected in the 2014/2015 epidemic, 3) recently accumulation of amino acid substitutions within the ON1 duplicated sequence, and 4) no clear evidence of altered pathogenicity relative to GA2. The study demonstrates the public health importance of molecular surveillance in defining the spread, clinical effects, and evolution of novel respiratory virus variants.

Original publication

DOI

10.3201/eid2302.161149

Type

Journal

Emerging infectious diseases

Publication Date

02/2017

Volume

23

Pages

264 - 271

Keywords

Humans, Respiratory Syncytial Virus, Human, Respiratory Syncytial Virus Infections, Viral Envelope Proteins, Odds Ratio, Amino Acid Substitution, Sequence Analysis, DNA, Evolution, Molecular, Phylogeny, Genotype, History, 21st Century, Child, Preschool, Infant, Infant, Newborn, Kenya, Female, Male, Genetic Variation, Public Health Surveillance